FOX NEWS:
NEW COVID-19 Saliva Test Available at Medical Facilities & Some Drive-Thru Test Centers
Watch interview below with Dr. Brooks, COO Rutgers
Aired April 15, 2020
Aired April 15, 2020
Fast-tracked EUA authorization for saliva-based COVID-19 testing only using Spectrum’s saliva collection device.
The EUA for saliva as a viable biosample in COVID-19 testing came from the result of detailed saliva vs. swab study strategically looking for an answer to the devastating swab and media supply shortages felt not only nationwide but globally. The study conclusion uncovered a novel, and technically robust testing alternative using saliva collected with Spectrum’s SDNA-1000 saliva collection device. These results fast-tracked EUA authorization for RUCDR Infinite Biologics – Rutgers Clinical Genomics Laboratory and its Perkin Elmer nucleic acid extraction and ThermoFisher TaqPath SARS-CoV-2 automated processes using the Spectrum Solutions SDNA-1000 device.
The Spectrum’s blue preservation solution in the SDNA-1000 was the main focus of the study to ensure that the virus would be inactivated to the point that we would be able to maintain and stabilizes the RNA transcripts for sensitive and specific QPCR analysis in order to determine whether a person has the virus, according to Dr. Brooks.
[photo] Dr. Andrew Brooks, Chief Operating Officer at RUCDR Infinite Biologics is processing Spectrum saliva collection devices which enable RUCDR to screen a much broader population without putting health care professionals at risk. Self-collection of saliva is vital in reducing the spread of COVID-19 as well as preserving personal protective equipment necessary for safe patient care.
Fast-tracked EUA authorization for saliva-based COVID-19 testing only using Spectrum’s saliva collection device.
The EUA for saliva as a viable biosample in COVID-19 testing came from the result of detailed saliva vs. swab study strategically looking for an answer to the devastating swab and media supply shortages felt not only nationwide but globally. The study conclusion uncovered a novel, and technically robust testing alternative using saliva collected with Spectrum’s SDNA-1000 saliva collection device. These results fast-tracked EUA authorization for RUCDR Infinite Biologics – Rutgers Clinical Genomics Laboratory and its Perkin Elmer nucleic acid extraction and ThermoFisher TaqPath SARS-CoV-2 automated processes using the Spectrum Solutions SDNA-1000 device.
The Spectrum’s blue preservation solution in the SDNA-1000 was the main focus of the study to ensure that the virus would be inactivated to the point that we would be able to maintain and stabilizes the RNA transcripts for sensitive and specific QPCR analysis in order to determine whether a person has the virus, according to Dr. Brooks.
[photo] Dr. Andrew Brooks, Chief Operating Officer at RUCDR Infinite Biologics is processing Spectrum saliva collection devices which enable RUCDR to screen a much broader population without putting health care professionals at risk. Self-collection of saliva is vital in reducing the spread of COVID-19 as well as preserving personal protective equipment necessary for safe patient care.
Spectrum
in the News
Spectrum
in the News
Noninvasive
Saliva Diagnostics
This changes everything!
Saliva analysis looks at the cellular level, the biologically active compounds, making it a true representative of what is clinically relevant. Engineered to lead the saliva collection industry, the BioMAX™ delivers the safest and most robust biosample for the earliest detection and diagnosis of disease and infection.
Since 2020 and the COVID-19 pandemic, Spectrum’s saliva collection system not only introduced, it continues to expand the molecular diagnostics industry and its understanding of the opportunities saliva offers patients, providers, and laboratories.
- Pain-free, non-invasive, & safe
- Saliva contains the entire library of proteins, hormones, antibodies, and other molecular compounds measured in routine blood tests
- First EUA-authorized saliva collection device for COVID-19 testing
- No temperature-controlled storage or transport of collected biosamples
- A single saliva sample provides opportunity for multiple tests
- Months and years of post-collection stability with no degradation in sample efficacy (depending on the analyte)
- Maintain critical bio-sample consistency
- Mitigates any risk of viral infection throughout the testing process
- Delivers the highest levels of testing accuracy using qualified extraction chemistries
Noninvasive
Saliva Diagnostics
This changes everything!
Saliva analysis looks at the cellular level, the biologically active compounds, making it a true representative of what is clinically relevant. Engineered to lead the saliva collection industry, the BioMAX™ delivers the safest and most robust biosample for the earliest detection and diagnosis of disease and infection.
Since 2020 and the COVID-19 pandemic, Spectrum’s saliva collection system not only introduced, it continues to expand the molecular diagnostics industry and its understanding of the opportunities saliva offers patients, providers, and laboratories.
Outside-of-the-Box Thinking, Inside-of-the-Box Innovation
Anywhere from customized testing solutions to new medical science product innovations–we’re here to help.